HSF1 and cancer: As HSF1 plays a pleiotropic role in cancer, its dysregulated expression in cancer and its relationship with the prognosis of cancer patients imply that HSF1 could be utilized as a biomarker for patient prognosis and a promising molecular target for cancer treatment and chemoprevention.